The Calm After the Storm. Long-Term Survival After Cardiogenic Shock**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 18, 2007, Pages 1759-1760

  Hochman, Judith S ^a   Apolito, Renato ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

CARDIOGENIC SHOCK; CORONARY ARTERY BYPASS GRAFT; EDITORIAL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; SHOCK, CARDIOGENIC; SURVIVAL RATE;

EID: 35348932598     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.07.046     Document Type: Editorial

References (11)

1. Hochman J.S., Sleeper L.A., White H.D., et al. One-year survival following early revascularization for cardiogenic shock. JAMA 285 (2001) 190-192
2. Klein L.W., Shaw R.E., Krone R.J., et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol 96 (2005) 35-41
3. Singh M., White J., Hasdai D., et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. J Am Coll Cardiol 50 (2007) 1752-1758
4. Antoniucci D., Valenti R., Santoro G.M., et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 31 (1998) 294-300
5. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295 (2006) 2511-2515
6. Ajani A.E., Maruff P., Warren R., et al. Impact of early percutaneous coronary intervention on short- and long-term outcomes in patients with cardiogenic shock after acute myocardial infarction. Am J Cardiol 87 (2001) 633-635
7. Lee L., Erbel R., Brown T.M., Laufer N., Meyer J., and O'Neill W.W. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol 17 (1991) 599-603
8. Sleeper L.A., Ramanathan K., Picard M.H., et al. Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 46 (2005) 266-273
9. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 44 (2004) 671-719
10. Alexander J.H., Reynolds H.R., Stebbins A.L., et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 297 (2007) 1657-1666
11. Armstrong P.W., Granger C.B., Adams P.X., et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 297 (2007) 43-51